David Moatazedi
See Remarks, Director, Evolus, Inc.; Director, Biomerica Inc
Bought, 12 months
$0.0M
Sold, 12 months
$1.7M
Companies
2
Latest trade
Sep 2, 2026
Companies
Evolus, Inc.See Remarks, Director −$1.7M Biomerica IncDirector +$0.0MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.

